News Blog
Panel Discussion on Decentralized Trials: A Real-World Example
Catalyst Clinical Research had the opportunity to exhibit at Arena International Event Group's Outsourcing in Clinical Trials USA Virtual Experience 2020. Additionally, our experts participated in a panel discussion on decentralized trials, discussing their use in a...
PJammin for Kids with Cancer
September is Childhood Cancer Awareness Month, and Catalyst and Ce3 are joining the efforts of St. Jude Children's Research Hospital leading the way in finding cures and saving children. St. Jude’s is a charity near and dear to the hearts of Catalyst and Ce3 as both...
Childhood Cancer Awareness
September is Childhood Cancer Awareness Month. Childhood cancer remains the leading cause of death by disease for children under the age of 14 with at least 400,000 children being diagnosed with cancer around the world each year. The World Health Organization is...
5 Tips to Navigate Working from Home During COVID-19
The Coronavirus has added a variety of new challenges and obstacles to working from home. More people at home mean more distractions. The internet connection is lagging. Cabin fever is at an all-time high. So, how can we cope with the current work from home...
Catalyst Named to 2020 Inc. 5000 List of Fastest-Growing Private Companies
Wilmington, NC, 12 August 2020 – For the first time, Wilmington-headquartered Catalyst Clinical Research appears on the Inc. 5000 list of fastest-growing private companies in America. Catalyst ranked 1235 on the list. Recognition on the Inc. 5000 list echoes...
Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO
Wilmington, NC, 4 August 2020 – Catalyst Clinical Research announced today that it has merged with Ce3, Inc. to expand its depth of oncology-specific therapeutic expertise. The combined company is strongly positioned to deliver oncology clinical development services...
